Psychiatry Letter's banner
Psychiatry Letter's profile picture

Psychiatry Letter

@NassirGhaemi • 1,079 subscribers

Scientific and humanistic psychiatry from Nassir Ghaemi MD MPH.

Videos

LIVE
1.2k

Anya Rossi

sweetdream.ai

SweetDream.aiSponsored•Livecam
Streaming Now

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

HD live stream
Exclusive private shows
1.2k viewers online

Free preview available • Premium content

Serotonin withdrawal syndrome, a controversial but significant issue, affects over 50% of patients on SRIs after a year or more of treatment. Early studies suggesting low rates are likely flawed. #Psychiatry #SRI #MentalHealth
1:25
NassirGhaemi's profile picture

Serotonin withdrawal syndrome, a controversial but significant issue, affects over 50% of patients on SRIs after a year or more of treatment. Early studies suggesting low rates are likely flawed. #Psychiatry #SRI #MentalHealth

Psychiatry Letter

27,727 views • 3 months ago

Patients on SSRIs get better. So do patients on placebo. Depression often resolves on its own. Controlling for that — no meaningful added benefit from the drug.
1:10
NassirGhaemi's profile picture

Patients on SSRIs get better. So do patients on placebo. Depression often resolves on its own. Controlling for that — no meaningful added benefit from the drug.

Psychiatry Letter

22,718 views • 3 months ago

SRIs have a Cohen's d of 0.3 for depression. For anxiety? It's 0.6 — double the benefit. These aren't antidepressants. They're anti-anxiety drugs marketed as antidepressants.
1:53
NassirGhaemi's profile picture

SRIs have a Cohen's d of 0.3 for depression. For anxiety? It's 0.6 — double the benefit. These aren't antidepressants. They're anti-anxiety drugs marketed as antidepressants.

Psychiatry Letter

21,598 views • 3 months ago

No more content to load